ID

28050

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Standard of care medications

Mots-clés

  1. 27/08/2017 27/08/2017 -
  2. 23/10/2017 23/10/2017 -
  3. 12/12/2017 12/12/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

12 décembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

Standard of care medications
Description

Standard of care medications

1. Was the subject regularly taking STATIN therapy for 8 weeks or more prior to randomisation?
Description

STATIN therapy prior to randomisation

Type de données

boolean

Alias
UMLS CUI [1]
C0360714
2. Was the subject taking STATIN therapy at the time of randomisation?
Description

STATIN therapy at randomisation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0360714
UMLS CUI [1,2]
C0034656
If no, indicate reason
Description

no STATIN therapy at randomisation reason

Type de données

text

Alias
UMLS CUI [1]
C0360714
If other reason, specify:
Description

no STATIN therapy at randomisation other reason

Type de données

text

Alias
UMLS CUI [1,1]
C0746919
UMLS CUI [1,2]
C3840932
3. Was the subject regularly taking ASPIRIN therapy for 8 weeks or more prior to randomisation?
Description

ASPIRIN therapy prior to randomisation

Type de données

boolean

Alias
UMLS CUI [1]
C4303556
4. Was the subject taking ASPIRIN at the time of randomisation?
Description

ASPIRIN at randomisation

Type de données

boolean

Alias
UMLS CUI [1]
C0004057
If no, indicate reason:
Description

no ASPIRIN at randomisation reason

Type de données

text

Alias
UMLS CUI [1]
C0004057
If other reason, specify:
Description

no ASPIRIN at randomisation other reason

Type de données

integer

Alias
UMLS CUI [1,1]
C0746919
UMLS CUI [1,2]
C3840932
UMLS CUI [1,3]
C0004057
5. Is the subject regularly taking any P2Y12 inhibitors (i.e. thienopyridines)?
Description

P2Y12 inhibitors

Type de données

boolean

Alias
UMLS CUI [1]
C2936585
If no, indicate reason:
Description

no P2Y12 inhibitors reason

Type de données

text

Alias
UMLS CUI [1]
C2936585
If other reason, specify:
Description

no P2Y12 inhibitors other reason

Type de données

text

Alias
UMLS CUI [1]
C2936585
6. Is the subject taking a beta-blocker?
Description

beta-blocker

Type de données

boolean

Alias
UMLS CUI [1]
C0001645
If no, indicate reason:
Description

no beta-blocker reason

Type de données

text

Alias
UMLS CUI [1]
C0001645
If other reason, specify:
Description

no beta-blocker other reason

Type de données

text

Alias
UMLS CUI [1]
C0001645
7. Is the subject taking an ACE inhibitor?
Description

ACE inhibitor

Type de données

boolean

Alias
UMLS CUI [1]
C0003015
If no, indicate reason:
Description

no ACE inhibitor reason

Type de données

text

Alias
UMLS CUI [1]
C0003015
If other reason, specify:
Description

no ACE inhibitors other reason

Type de données

text

Alias
UMLS CUI [1]
C0003015
8. Is the subject taking an ARB?
Description

ARB

Type de données

boolean

Alias
UMLS CUI [1]
C0521942
If no, indicate reason:
Description

no ARB reason

Type de données

text

Alias
UMLS CUI [1]
C0521942
If other reason, specify:
Description

no ARB other reason

Type de données

text

Alias
UMLS CUI [1,1]
C0746919
UMLS CUI [1,2]
C3840932
UMLS CUI [1,3]
C0521942
9. Is the subject taking any other renin-angiotensin-aldosterone system-targeted medication?
Description

renin-angiotensin-aldosterone system-targeted medication

Type de données

boolean

Alias
UMLS CUI [1]
C3653735
If no, indicate reason:
Description

no renin-angiotensin-aldosterone system-targeted medication reason

Type de données

text

Alias
UMLS CUI [1]
C3653735
If other reason, specify:
Description

no renin-angiotensin-aldosterone system-targeted medication other reason

Type de données

text

Alias
UMLS CUI [1]
C3653735

Similar models

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Standard of care medications
STATIN therapy prior to randomisation
Item
1. Was the subject regularly taking STATIN therapy for 8 weeks or more prior to randomisation?
boolean
C0360714 (UMLS CUI [1])
STATIN therapy at randomisation
Item
2. Was the subject taking STATIN therapy at the time of randomisation?
boolean
C0360714 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Item
If no, indicate reason
text
C0360714 (UMLS CUI [1])
Code List
If no, indicate reason
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
no STATIN therapy at randomisation other reason
Item
If other reason, specify:
text
C0746919 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
ASPIRIN therapy prior to randomisation
Item
3. Was the subject regularly taking ASPIRIN therapy for 8 weeks or more prior to randomisation?
boolean
C4303556 (UMLS CUI [1])
ASPIRIN at randomisation
Item
4. Was the subject taking ASPIRIN at the time of randomisation?
boolean
C0004057 (UMLS CUI [1])
Item
If no, indicate reason:
text
C0004057 (UMLS CUI [1])
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
no ASPIRIN at randomisation other reason
Item
If other reason, specify:
integer
C0746919 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
C0004057 (UMLS CUI [1,3])
P2Y12 inhibitors
Item
5. Is the subject regularly taking any P2Y12 inhibitors (i.e. thienopyridines)?
boolean
C2936585 (UMLS CUI [1])
Item
If no, indicate reason:
text
C2936585 (UMLS CUI [1])
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no P2Y12 inhibitors other reason
Item
If other reason, specify:
text
C2936585 (UMLS CUI [1])
beta-blocker
Item
6. Is the subject taking a beta-blocker?
boolean
C0001645 (UMLS CUI [1])
Item
If no, indicate reason:
text
C0001645 (UMLS CUI [1])
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no beta-blocker other reason
Item
If other reason, specify:
text
C0001645 (UMLS CUI [1])
ACE inhibitor
Item
7. Is the subject taking an ACE inhibitor?
boolean
C0003015 (UMLS CUI [1])
Item
If no, indicate reason:
text
C0003015 (UMLS CUI [1])
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no ACE inhibitors other reason
Item
If other reason, specify:
text
C0003015 (UMLS CUI [1])
ARB
Item
8. Is the subject taking an ARB?
boolean
C0521942 (UMLS CUI [1])
Item
If no, indicate reason:
text
C0521942 (UMLS CUI [1])
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no ARB other reason
Item
If other reason, specify:
text
C0746919 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
C0521942 (UMLS CUI [1,3])
renin-angiotensin-aldosterone system-targeted medication
Item
9. Is the subject taking any other renin-angiotensin-aldosterone system-targeted medication?
boolean
C3653735 (UMLS CUI [1])
Item
If no, indicate reason:
text
C3653735 (UMLS CUI [1])
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no renin-angiotensin-aldosterone system-targeted medication other reason
Item
If other reason, specify:
text
C3653735 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial